Tuesday, May 5, 2015

Deals

Immune, STC Partner

May 4, 2015 · Leave a Comment 

  Immune Pharmaceuticals will use STC Biologics’ antibodies in a strategic partnership intended to speed up the development of Immune’s antibody nanoparticle conjugates or NanomAbs, designed to allow targeted delivery of chemotherapeutics, the companies said today. The value of the collaboration was not disclosed. The companies said their partnership will draw upon research capabilities of STC in Cambridge, MA, and of Immune in Jerusalem. Development will initially focus on HER2-targeted paclitaxel nanoparticles using an anti-HER2 monoclonal antibody developed by STC, as well as H-Ferritin... [Read the full story]

Deal News

Immune, STC Partner

May 4, 2015 · Leave a Comment 

  Immune Pharmaceuticals will use STC Biologics’ antibodies in a strategic partnership intended to speed up the development of Immune’s antibody nanoparticle conjugates or NanomAbs, designed to allow targeted delivery of chemotherapeutics, the companies said today. The value of the collaboration was not disclosed. The companies said their partnership will draw upon research capabilities of STC in Cambridge, MA, and of Immune in Jerusalem. Development will initially focus on HER2-targeted paclitaxel nanoparticles using an anti-HER2 monoclonal antibody developed by STC, as well as H-Ferritin... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

R-Tech Ueno buys commercialization rights from Santen Pharma

April 30, 2015 · Leave a Comment 

  R-Tech Ueno, Ltd, engaged in the research, development, manufacture, and sale of pharmaceutical products for the treatment of ophthalmology and dermatology worldwide, has acquired the right to develop and commercialize DE-105 from Santen Pharmaceutical Company, Ltd. DE-105 is a treatment targeting at persistent corneal epithelial defects that Santen has been developing. By acquisition of this right, R-Tech Ueno undertakes development of this agent towards commercialisation going forward. “Moreover, we have also concluded an agreement with the inventor of DE-105, Professor Emeritus Teruo... [Read the full story]

University Tech Transfer

Anivax Licenses UA-Developed Poultry Vaccine

May 2, 2015 · Leave a Comment 

  Anivax and the University of Arizona have announced an agreement to license several technologies developed in a broad-based collaborative effort between the UA and Arizona State University. The license is for a revolutionary Campylobacter food safety vaccine designed to be administered to poultry to reduce colonization by the bacteria and ultimately lower the incidence of human disease and associated conditions. The team of inventors includes individuals from both institutions, including: Bibiana Law, associate research professor in the UA School of Animal and Comparative Biomedical Sciences,... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Immune, STC Partner

  Immune Pharmaceuticals will use STC Biologics’ antibodies in a strategic partnership intended to speed up the development of Immune’s antibody nanoparticle conjugates or NanomAbs, designed to allow targeted delivery of chemotherapeutics, the companies said today. The value of the collaboration was not disclosed. The companies said their... Read more of this article


ExxonMobil Awards License to EON Reality

  ExxonMobil Research Qatar (EMRQ) today announced that ExxonMobil has awarded a global commercial license for Immersive 3D Operator Training Simulator technology to co-developer EON Reality Inc. The innovative technology incorporates ultra-realistic, multi-angle immersive virtual reality for training process operators and engineers in oil... Read more of this article


FADEL and ADAM Software Enter into Sales and Technology Partnership

  FADEL, creators of enterprise-class Intellectual Property Rights and Royalty Management software, today announced that it has entered into a strategic alliance with ADAM Software, a leading Digital Asset Management (DAM) and Product Content Management (PCM) software provider. The two companies are partnering to extend ADAM’s Digital Asset... Read more of this article


PearTrack Security Systems, Inc. Completes Exclusive License

  SANTA MONICA, CA, United States, via ETELIGIS INC., 05/04/2015 – – PearTrack Security Systems, Inc. (OTCQB: PTSS) (“PearTrack”), today announced it has completed the key acquisition of the patented container locking system, through an exclusive license of the intellectual property from PearLoxx Limited, a UK company. The... Read more of this article


Electrovaya’s Acquisition Of Evonik Litarion GmbH Complete

  The noted Canadian lithium-ion battery developer/manufacturer Electrovaya has completed its acquisition of Evonik Litarion GmbH — along with completing the licensing process for the “SEPARION” ceramic composite separator — according to a recent press release. The completion of the process means that Evonik Litarion’s automated lithium-ion... Read more of this article


Yaskawa Motoman licenses ultrasonic technology

  Yaskawa Motoman, a global robotics manufacturer headquartered in Miamisburg, has entered into a multi-year license agreement with Nihon Shoryoku Co. Ltd., company officials announced. Under terms of the agreement, Yaskawa Motoman will have exclusive rights in the Americas for the technology, manufacturing and sales of NSK’s ultrasonic cutting... Read more of this article


SDI Signs Strategic Technology License & Supply Agreement

  Florida, Tampa – Security Devices International Inc. (“SDI” or “the Company”) today announced the signing of a five-year, non-exclusive, renewable Technology License and Supply Agreement (“TLSA”) with United Tactical Solutions (“UTS”) of Chicago, IL. UTS is a global provider of specialized... Read more of this article


World Patent Marketing China Signs A Licensing Agreement

  SHANGHAI, China, May 1, 2015 (GLOBE NEWSWIRE) — via PRWEB – World Patent Marketing, a vertically integrated manufacturer and distributor of patented products, is pleased to announce that it has successfully negotiated a licensing deal for a Kansas inventor. The manufacturer is none other than World Patent Marketing China, World Patent... Read more of this article


Anivax Licenses UA-Developed Poultry Vaccine

  Anivax and the University of Arizona have announced an agreement to license several technologies developed in a broad-based collaborative effort between the UA and Arizona State University. The license is for a revolutionary Campylobacter food safety vaccine designed to be administered to poultry to reduce colonization by the bacteria and ultimately... Read more of this article


Spark acquires rights to license Clearside’s technology

  Spark Therapeutics, Inc., a gene therapy leader,  and Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company, have entered into an option agreement under which Spark acquired exclusive rights to license Clearside’s microinjector technology to deliver gene therapies to the back of the eye. Under the agreement, the companies... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Anivax Licenses UA-Developed Poultry Vaccine

  Anivax and the University of Arizona have announced an agreement to license... 


Bellicum Pharmaceuticals Licenses TCR Technology From Leiden University Medical Center

  Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical... 


More Posts From University Tech Transfer